Literature DB >> 26437614

Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants.

A P Duarte de Souza1,2,3, D Nascimento de Freitas1,2,3, K E Antuntes Fernandes1,2,3, M D'Avila da Cunha1,2,3, J L Antunes Fernandes1,2,3, R Benetti Gassen1,2,3, T Fazolo1,2,3, L A Pinto4,2,3, M Scotta4,2,3, R Mattiello4,2,3, P M Pitrez4,2,3, C Bonorino5,3, R T Stein4,2,3.   

Abstract

Respiratory syncytial virus (RSV)-specific CD8(+) T cell responses do not protect against reinfection. Activation of mammalian target of rapamycin (mTOR) impairs memory CD8(+) T cell differentiation. Our hypothesis was that RSV inhibits the formation of CD8(+) T cells memory responses through mTOR activation. To explore this, human and mouse T cells were used. RSV induced mTOR phosphorylation at Ser2448 in CD8 T cells. mTOR activation by RSV was completely inhibited using rapamycin. RSV-infected children presented higher mTOR gene expression on nasal washes comparing to children infected with metapneumovirus and rhinovirus. In addition, RSV-infected infants presented a higher frequency of CD8(+) pmTORser2448(+) T cells in nasal washes compared to RSV-negative infants. Rapamycin treatment increased the frequency of mouse CD8 RSV-M282-90 pentamer-positive T cells and the frequency of RSV-specific memory T cells precursors. These data demonstrate that RSV is activating mTOR directly in CD8 T cells, indicating a role for mTOR during the course of RSV infection.
© 2015 British Society for Immunology.

Entities:  

Keywords:  CD8+ T cells; RSV; RSV-infected infants; mTOR; nasal washes

Mesh:

Substances:

Year:  2015        PMID: 26437614      PMCID: PMC4711155          DOI: 10.1111/cei.12720

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response.

Authors:  Alexander Kotelkin; Igor M Belyakov; Lijuan Yang; Jay A Berzofsky; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  West nile virus-induced activation of mammalian target of rapamycin complex 1 supports viral growth and viral protein expression.

Authors:  Katherine D Shives; Erica L Beatman; Mastooreh Chamanian; Caitlin O'Brien; Jody Hobson-Peters; J David Beckham
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

4.  Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact.

Authors:  Jörg Schlender; Gunther Walliser; Jens Fricke; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope.

Authors:  Maria Castedo; Thomas Roumier; Julià Blanco; Karine F Ferri; Jordi Barretina; Lionel A Tintignac; Karine Andreau; Jean-Luc Perfettini; Alessandra Amendola; Roberta Nardacci; Philip Leduc; Donald E Ingber; Sabine Druillennec; Bernard Roques; Serge A Leibovitch; Montserrat Vilella-Bach; Jie Chen; José A Este; Nazanine Modjtahedi; Mauro Piacentini; Guido Kroemer
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

6.  Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection.

Authors:  A K Behera; H Matsuse; M Kumar; X Kong; R F Lockey; S S Mohapatra
Journal:  Biochem Biophys Res Commun       Date:  2001-01-12       Impact factor: 3.575

7.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

8.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

9.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

Authors:  Homero San-Juan-Vergara; Mark E Peeples
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-22       Impact factor: 3.479

2.  Low-Dose Cadmium Potentiates Metabolic Reprogramming Following Early-Life Respiratory Syncytial Virus Infection.

Authors:  Zachery R Jarrell; Matthew Ryan Smith; Ki-Hye Kim; Youri Lee; Xin Hu; Xiaojia He; Michael Orr; Yan Chen; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Toxicol Sci       Date:  2022-06-28       Impact factor: 4.109

Review 3.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 4.  Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway.

Authors:  Valerie Le Sage; Alessandro Cinti; Raquel Amorim; Andrew J Mouland
Journal:  Viruses       Date:  2016-05-24       Impact factor: 5.048

5.  Incomplete Memories: The Natural Suppression of Tissue-Resident Memory CD8 T Cells in the Lung.

Authors:  Katie L Reagin; Kimberly D Klonowski
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

Review 6.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

7.  Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types.

Authors:  Lydia J Atherton; Patricia A Jorquera; Abhijeet A Bakre; Ralph A Tripp
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

8.  Rapamycin Improves the Response of Effector and Memory CD8+ T Cells Induced by Immunization With ASP2 of Trypanosoma cruzi.

Authors:  Barbara Ferri Moraschi; Isaú Henrique Noronha; Camila Pontes Ferreira; Leonardo M Cariste; Caroline B Monteiro; Priscila Denapoli; Talita Vrechi; Gustavo J S Pereira; Ricardo T Gazzinelli; Joseli Lannes-Vieira; Maurício M Rodrigues; Karina R Bortoluci; José Ronnie C Vasconcelos
Journal:  Front Cell Infect Microbiol       Date:  2021-05-25       Impact factor: 5.293

9.  The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States.

Authors:  Pasquale Laise; Gideon Bosker; Xiaoyun Sun; Yao Shen; Eugene F Douglass; Charles Karan; Ronald B Realubit; Sergey Pampou; Andrea Califano; Mariano J Alvarez
Journal:  bioRxiv       Date:  2020-05-17

Review 10.  Strategies for active and passive pediatric RSV immunization.

Authors:  Katherine M Eichinger; Jessica L Kosanovich; Madeline Lipp; Kerry M Empey; Nikolai Petrovsky
Journal:  Ther Adv Vaccines Immunother       Date:  2021-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.